Related Experiment Video
Updated: Nov 16, 2025
Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
Published on: August 2, 2018
Identification of proteins and cellular pathways targeted by 2-nitroimidazole hypoxic cytotoxins
Faisal Bin Rashed1, Alexandru Cezar Stoica1, Dawn MacDonald1
1Department of Oncology, University of Alberta, Edmonton, AB, T6G2R3, Canada.
Abstract:
Tumour hypoxia negatively impacts therapy outcomes and continues to be a major unsolved clinical problem. Nitroimidazoles are hypoxia selective compounds that become entrapped in hypoxic cells by forming drug-protein adducts. They are widely used as hypoxia diagnostics and have also shown promise as hypoxia-directed therapeutics. However, little is known about the protein targets of nitroimidazoles and the resulting effects of their modification on cancer cells. Here, we report the synthesis and applications of azidoazomycin arabinofuranoside (N3-AZA), a novel click-chemistry compatible 2-nitroimidazole, designed to facilitate (a) the LC-MS/MS-based proteomic analysis of 2-nitroimidazole targeted proteins in FaDu head and neck cancer cells, and (b) rapid and efficient labelling of hypoxic cells and tissues. Bioinformatic analysis revealed that many of the 62 target proteins we identified participate in key canonical pathways including glycolysis and HIF1A signaling that play critical roles in the cellular response to hypoxia. Critical cellular proteins such as the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and the detoxification enzyme glutathione S-transferase P (GSTP1) appeared as top hits, and N3-AZA adduct formation significantly reduced their enzymatic activities only under hypoxia. Therefore, GAPDH, GSTP1 and other proteins reported here may represent candidate targets to further enhance the potential for nitroimidazole-based cancer therapeutics.
Insights
This study identifies key protein targets of nitroimidazoles in hypoxic cancer cells. Targeting proteins like GAPDH and GSTP1 could improve hypoxia-directed cancer therapies.
Area of Science:
- Biochemistry
- Cancer Biology
- Proteomics
Background:
- Tumour hypoxia is a significant challenge in cancer therapy, impacting treatment outcomes.
- Nitroimidazoles are hypoxia-selective agents used in diagnostics and therapeutics, but their specific protein targets remain largely unknown.
- Understanding these targets is crucial for developing more effective nitroimidazole-based cancer treatments.
Purpose of the Study:
- To synthesize and utilize a novel click-chemistry compatible 2-nitroimidazole, azidoazomycin arabinofuranoside (N3-AZA).
- To identify and characterize the protein targets of 2-nitroimidazoles in hypoxic head and neck cancer cells.
- To investigate the functional impact of N3-AZA adduct formation on identified protein targets.
Main Methods:
- Synthesis of azidoazomycin arabinofuranoside (N3-AZA), a click-chemistry compatible 2-nitroimidazole.
- Liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based proteomics to identify N3-AZA protein adducts in FaDu head and neck cancer cells.
- Bioinformatic analysis of identified target proteins and their associated canonical pathways.
Main Results:
- Identification of 62 unique protein targets for 2-nitroimidazoles in hypoxic cancer cells.
- Bioinformatic analysis revealed enrichment of targets in critical hypoxia-related pathways, including glycolysis and HIF1A signaling.
- Key proteins, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and glutathione S-transferase P (GSTP1), were identified as top hits, with N3-AZA adducts reducing their enzymatic activity under hypoxia.
Conclusions:
- N3-AZA is an effective tool for identifying nitroimidazole protein targets and labeling hypoxic cells.
- Identified proteins, particularly GAPDH and GSTP1, are potential therapeutic targets for enhancing nitroimidazole-based cancer treatments.
- Further investigation into these targets may lead to improved strategies for overcoming tumour hypoxia in cancer therapy.
Related Concept Videos
01:46Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
02:26Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...